Safety Data SheetChemical Risk Assessment
SeroELISA Chlamydia IgA (113-01), SeroELISA Chlamydia IgG (111-01), SeroELISA Chlamydia IgM (112-01), SeroCT IgG (181-01), SeroCT IgA (183-01), ), SeroCT Rt IgG (1181-01), SeroCT Rt IgA (1183-01), SeroCP IgG (191-01), SeroCP IgM (192-01), SeroCP IgA (193-01), SeroCP Rt IgG (1191-01), SeroCP Rt IgM (1192-01), SeroCP Rt IgA (1193-01), SeroMP IgG (261-01), SeroMP IgM (262-01), SeroMP IgA (263-01), SeroMP Recombinant IgG (1261-01), SeroMP Recombinant IgM (1262-01), SeroMP Recombinant IgA (1263-01), SeroCP Quant IgG (291-01), SeroCP Quant IgA (293-01), SeroPertussis IgG (231-01), SeroPertussis IgA/IgM (233-01). SeroPertussis Toxin IgG (1231-01) SeroPertussis Toxin IgA (1233-01) Bordetella Pertussis IgG (2231-01) SeroHSV1 (240-01), SeroHSV2 (250-01), SeroHSV IgG (151-01), SeroHSV IgM (152-01)
by Savyon Diagnostics
SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB
SeroELISA Chlamydia IgA (113-01), SeroELISA Chlamydia IgG (111-01), SeroELISA Chlamydia IgM (112-01), SeroCT IgG (181-01), SeroCT IgA (183-01), ), SeroCT Rt IgG (1181-01), SeroCT Rt IgA (1183-01), SeroCP IgG (191-01), SeroCP IgM (192-01), SeroCP IgA (193-01), SeroCP Rt IgG (1191-01), SeroCP Rt IgM (1192-01), SeroCP Rt IgA (1193-01), SeroMP IgG (261-01), SeroMP IgM (262-01), SeroMP IgA (263-01), SeroMP Recombinant IgG (1261-01), SeroMP Recombinant IgM (1262-01), SeroMP Recombinant IgA (1263-01), SeroCP Quant IgG (291-01), SeroCP Quant IgA (293-01), SeroPertussis IgG (231-01), SeroPertussis IgA/IgM (233-01). SeroPertussis Toxin IgG (1231-01) SeroPertussis Toxin IgA (1233-01) Bordetella Pertussis IgG (2231-01) SeroHSV1 (240-01), SeroHSV2 (250-01), SeroHSV IgG (151-01), SeroHSV IgM (152-01) is supplied by Savyon Diagnostics. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 1 April 2016. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
- Language
- English
- Regulation
- GHS/CLP
- Revision Date
- 01 Apr 2016
- Signal Word
- WARNING
- Product Code
- —
- CAS Number
- 54827-17-7
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: WARNING
GHS07Harmful / irritantHazard Statements (H-phrases)
- H319
- Causes serious eye irritation.
- H315
- Causes skin irritation.
- H335
- May cause respiratory irritation.
Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.
Common QuestionsAbout this Safety Data Sheet
This Safety Data Sheet was issued by Savyon Diagnostics on 1 April 2016 under GHS/CLP. ISDSS syncs its database regularly to keep documents current.
Yes, a free ISDSS account is required to download the PDF. Registration takes under two minutes and gives you access to over 1.5 million Safety Data Sheets. Once registered, you can also save documents to your personal library for quick access.
The manufacturer, importer or supplier that places the substance on the market is responsible for providing a current Safety Data Sheet to downstream users, free of charge.
No. An SDS provides the hazard information you need, but a COSHH assessment must consider how the substance is actually used in your workplace. The matching Chemical Risk Assessment (CRA) on this page is a starting point you should adapt to your own tasks and controls.
Chemical Risk Assessment SummaryFrom the Chemical Risk Assessment
Assessment Summary
This Chemical Risk Assessment is derived from the Safety Data Sheet for SeroELISA Chlamydia IgA (113-01), SeroELISA Chlamydia IgG (111-01), SeroELISA Chlamydia IgM (112-01), SeroCT IgG (181-01), SeroCT IgA (183-01), ), SeroCT Rt IgG (1181-01), SeroCT Rt IgA (1183-01), SeroCP IgG (191-01), SeroCP IgM (192-01), SeroCP IgA (193-01), SeroCP Rt IgG (1191-01), SeroCP Rt IgM (1192-01), SeroCP Rt IgA (1193-01), SeroMP IgG (261-01), SeroMP IgM (262-01), SeroMP IgA (263-01), SeroMP Recombinant IgG (1261-01), SeroMP Recombinant IgM (1262-01), SeroMP Recombinant IgA (1263-01), SeroCP Quant IgG (291-01), SeroCP Quant IgA (293-01), SeroPertussis IgG (231-01), SeroPertussis IgA/IgM (233-01). SeroPertussis Toxin IgG (1231-01) SeroPertussis Toxin IgA (1233-01) Bordetella Pertussis IgG (2231-01) SeroHSV1 (240-01), SeroHSV2 (250-01), SeroHSV IgG (151-01), SeroHSV IgM (152-01) issued by Savyon Diagnostics on 1 April 2016 It presents the substance's hazards organised by risk level, with the relevant regulatory statements and recommended controls for each. These hazards are rated across two levels: High and Low Risk, based on the hazard classifications in the SDS.
Hazard PreviewA snapshot of substance hazards and controls
Rating Before Controls
HIGH RISK
H319: Causes serious eye irritation
P264 Wash skin thoroughly after handling.
P280: Wear protective gloves/protective clothing/eye protection/face protection.
P305 + P351 + P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P313 + P337 If eye irritation persists Get medical advice/attention
Rating Before Controls
LOW RISK
H315: Causes skin irritation
P264 Wash skin thoroughly after handling.
P280: Wear protective gloves/protective clothing/eye protection/face protection.
P362 Take off contaminated clothing and wash before reuse.
P302 + P352 IF ON SKIN: wash with plenty of soap and water
P321 Specific treatment (see … on this label)
P332 + P313 IF SKIN irritation occurs: Get medical advice/attention.
Rating Before Controls
LOW RISK
H335: May cause respiratory irritation
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up
P501 Dispose of contents/container to correct disposal area.
P312 Call a POISON CENTER or doctor/physician if you feel unwell
1 other control in place
Note: This is a preview of the substance's hazards. A substance commonly carries more hazards. Download the full Chemical Risk Assessment for more information.
Recommended Control MeasuresKey PPE and handling controls
Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.
Common QuestionsAbout this Risk Assessment
This Chemical Risk Assessment provides the substance-level hazard inputs needed for a COSHH assessment under the UK Control of Substances Hazardous to Health Regulations 2002. It is not a substitute for a full workplace risk assessment. You must combine this with your own assessment of how the substance is actually used on your site, including task specifics, exposure duration and local controls.
The CRA is derived from the hazard data in the manufacturer's SDS for SeroELISA Chlamydia IgA (113-01), SeroELISA Chlamydia IgG (111-01), SeroELISA Chlamydia IgM (112-01), SeroCT IgG (181-01), SeroCT IgA (183-01), ), SeroCT Rt IgG (1181-01), SeroCT Rt IgA (1183-01), SeroCP IgG (191-01), SeroCP IgM (192-01), SeroCP IgA (193-01), SeroCP Rt IgG (1191-01), SeroCP Rt IgM (1192-01), SeroCP Rt IgA (1193-01), SeroMP IgG (261-01), SeroMP IgM (262-01), SeroMP IgA (263-01), SeroMP Recombinant IgG (1261-01), SeroMP Recombinant IgM (1262-01), SeroMP Recombinant IgA (1263-01), SeroCP Quant IgG (291-01), SeroCP Quant IgA (293-01), SeroPertussis IgG (231-01), SeroPertussis IgA/IgM (233-01). SeroPertussis Toxin IgG (1231-01) SeroPertussis Toxin IgA (1233-01) Bordetella Pertussis IgG (2231-01) SeroHSV1 (240-01), SeroHSV2 (250-01), SeroHSV IgG (151-01), SeroHSV IgM (152-01), mapped against standard workplace task profiles. It is updated in line with SDS revisions. The CRA is a starting point for your own assessment, not a finished document.
A Safety Data Sheet is produced by the manufacturer and describes the hazards of the substance itself. A Chemical Risk Assessment evaluates those hazards in the context of how the substance is actually used in the workplace, covering specific tasks, exposure routes and recommended controls. Both documents work together.
Yes, a free ISDSS account gives you access to both the SDS and the linked CRA for over 1.5 million substances. Registration takes under two minutes.